Toggle navigation
Home
Sitemap
日本語
Search
About Astellas
Contact Us
Search
Only Astellas completed Studies will be displayed.
Please select values from or type values into dropdown menus below, and click Search button to proceed.
To view all studies, leave all values blank and click Search.
Therapeutic Area:
Cardiovascular
Central Nervous System
Diabetes
Gastrointestinal
Infectious diseases
Inflammation and Immunology
Nephrology
Oncology
Pain
Transplantation
Urology
Medical Indication or Disease:
Adrenocortical carcinoma
Aggressive schizophrenia
Antineoplastic drug-induced nausea and vomiting
Bipolar depression
Bone marrow transplantation
Chronic kidney disease
Clostridium difficile infection
Clostridium Difficile-associated Diarrhea
Constipation-predominant irritable bowel syndrome
Deep mycosis
Diabetic kidney disease
Diarrhea-predominant irritable bowel syndrome
Functional dyspepsia
Hepatocellular carcinoma
Herpes Zoster
Hyperphosphatemia
Hyperphosphatemia (non-dialysis)
Hypertensive emergency
Insomnia
Invasive fungal infection
Lower urinary tract syndrome/ Benign prostatic hyperplasia
Lupus nephritis
Major depressive disorder
Myasthenia gravis
Myocardial perfusion imaging
Nephrotic syndrome
Neurogenic detrusor overactivity
Non-small cell lung cancer
Ovarian cancer
Overactive bladder
Painful diabetic neuropathy
Pancreatic cancer
Pediatric Solid Organ Transplantation
Pediatric Transplantation
Peripheral hematopoietic stem cell transplantation
Peripheral Neuropathic Pain
Prevention of rejection after organ transplant
Prostate cancer
Restless leg syndrome
Rheumatoid arthritis
Solid tumors
Treatment of solid tumors
Type 2 diabetes mellitus
Ulcerative colitis
Vernal keratoconjunctivitis
Compound Name:
ASP0456/Linaclotide
ASP1585 / bixalomer
ASP1707/ASP1707
ASP1941 / ipragliflozin
ASP2151/amenamevir
ASP3325/ASP3325
ASP3550/degarelix acetate
ASP5878/ASP5878
ASP7015 / leuprorelin acetate
ASP7487/OSI-906/linsitinib
ASP7991/ASP7991
ASP8232/ASP8232
ASP8273/naquotinib mesilate
ASP8477/ASP8477
ASP8825 / gabapentin enacarbil
ASP9766 (BAL8557)/ Isavuconazonium sulfate
ATG-F/Anti-T-lymphocyte Immune Globulin
AY4166 / Nateglinide
CDP870/Certolizumab pegol
CVT-3146/ ASP3606/regadenoson
EB178 / mirabegron + solifenacin succinate
EC905 / solifenacin + tamsulosin
FK199 / Zolpidem tartrate
FK463/micafungin
FK506/ tacrolimus
FK506/Tacrolimus
FK506E/ tacrolimus extended-release
FK949E/ quetiapine fumarate
Lodopin / Zotepine
MDV3100 (ASP9785) / enzalutamide
NGX-4010 (ASP0805)/capsaicin
OPT-80/ Fidaxomicin
OSI-774/ erlotinib
YC93/Nicardipine Hydrochloride
YM060/Ramosetron hydrochloride
YM178 / mirabegron
YM443/acotiamide hydrochloride hydrate
YM617/Tamsulosin HCl
YM905/solifenacin succinate
Study ID:
Format: XXXX-CL-XXXX
USEFUL LINKS
ClinicalTrials.gov
ClinicalTrialsRegister.eu
ClinicalTrials.jp
European Federation of Pharmaceutical Industries and Associations
European Public Asssessment Report (for Drug products approved by EMA)
FDA Approved Drug Products
FDA PostMarket Drug Safety Information for Patients and Providers (for Drug products approved by EMA)
PhRMA